Identification of candidates for coronary artery bypass grafting admitted with STEMI and Multivessel Disease

被引:6
|
作者
Rodriguez-Olivares, Ramon [1 ,2 ]
Lopez-Menendez, Jose [3 ]
Varela Barca, Laura [3 ]
Miguelena Hycka, Javier [3 ]
Hernandez-Antolin, Rosana [1 ,2 ]
Rodriguez-Roda Stuart, Jorge [3 ]
Zamorano Gomez, Jose L. [1 ,2 ]
机构
[1] Ramon y Cajal Univ Hosp, Dept Cardiol, Ctra Colmenar Viejo,Km 9,100, Madrid 28034, Spain
[2] Ctr Invest Blomed Red Cardiovasc CIBERCV, Madrid, Spain
[3] Raman y Cajal Univ Hosp, Dept Cardiac Surg, Madrid, Spain
关键词
STEMI; Multivessel coronary artery disease; CABG;
D O I
10.1016/j.carrev.2018.06.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The optimal management of patients with multivessel coronary artery disease (MVD) admitted with STEMI is under debate. CABG is rarely performed, even on ideal candidates. A provisional PCI without stent implantation may allow complete surgical revascularization (CSR) in a subset of patient that we sought to identify in this study. Methods: Patients with STEMI from April 2014 to October 2016 were evaluated and those with a TIMI flow <3 in the culprit vessel, and an additional stenosis of >70% in an epicardial vessel or sidebranch >2.5 mm were selected. Epidemiological variables, surgical risk scores and SYNTAX and SYNTAX II scores were analyzed. All the selected patients were discussed in a post hoc heart-team, and predictors of 12-month events were also analyzed. Results: Seventy-two (19.0%) accomplished MVD criteria. Mean SYNTAX was 19 +/- 13 points and SYNTAX II score recommended CABG in 12 patients (16.7%) and heart-team discussion in 60 (83.3%). All patients were discussed in a post hoc heart-team, which concluded that 21 (29.2%) patients could have been good candidates for CSR. After one year follow-up, SYNTAX II PCI > 40 was found to be the sole independent predictor for 12-month events (OR 12.9[2.7-62.1], p = 0.001). Conclusions: MVD and STEMI with a SYNTAX II PCI > 40 should be discussed in an ad-hoc heart team, after a provisional revascularization of the culprit vessel, and should be considered for CSR, especially when the RCA is the culprit artery and there is a complex disease in the left coronary artery. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:S21 / S26
页数:6
相关论文
共 50 条
  • [21] Anesthetic Management of Coronary Artery Bypass Grafting in a Patient with Charcot-Marie-Tooth Disease and Multivessel Coronary Artery Disease
    Rawson, Joshua
    Hayanga, J. W. Awori
    Varga, Jessica L.
    Bozek, John S.
    Hayanga, Heather K.
    AMERICAN JOURNAL OF CASE REPORTS, 2023, 24 : e940284
  • [22] Sequential free right internal thoracic artery grafting for multivessel coronary artery bypass grafting
    Fukui, Toshihiro
    Tabata, Minoru
    Morita, Satoshi
    Takanashi, Shuichiro
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (04): : 824 - 829
  • [23] Coronary Artery Bypass Grafting and Percutaneous Coronary Intervention in Patients With Chronic Total Occlusion and Multivessel Disease
    Lin, Shen
    Guan, Changdong
    Wu, Fan
    Xie, Lihua
    Zou, Tongqiang
    Shi, Yanpu
    Chen, Sipeng
    He, Li
    Xu, Bo
    Zheng, Zhe
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2022, 15 (02) : 150 - 159
  • [24] Hybrid Coronary Revascularization Versus Coronary Artery Bypass Grafting in Patients with Multivessel Coronary Artery Disease, A Meta-Analysis
    Sardar, Partha
    JACC-CARDIOVASCULAR INTERVENTIONS, 2017, 10 (03) : S20 - S21
  • [25] Hybrid coronary revascularization versus coronary artery bypass grafting in patients with multivessel coronary artery disease: A meta-analysis
    Sardar, Partha
    Kundu, Amartya
    Bischoff, Michelle
    Chatterjee, Saurav
    Owan, Theophilus
    Nairooz, Ramez
    Giri, Jay
    Halkos, Michael E.
    Liberman, Henry
    Douglas, John S.
    Mukherjee, Debabrata
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2018, 91 (02) : 203 - 212
  • [26] Comparison of Hybrid Coronary Revascularization Versus Coronary Artery Bypass Grafting in Patients ≥65 Years With Multivessel Coronary Artery Disease
    Harskamp, Ralf E.
    Puskas, John D.
    Tijssen, Jan G.
    Walker, Patrick F.
    Liberman, Henry A.
    Lopes, Renato D.
    Vassiliades, Thomas A.
    Peterson, Eric D.
    Halkos, Michael E.
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (02): : 224 - 229
  • [27] Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting for the Treatment of Multivessel Coronary Artery Disease
    Halkos, Michael E.
    Vassiliades, Thomas A.
    Douglas, John S.
    Morris, Douglas C.
    Rab, S. Tanveer
    Liberman, Henry A.
    Samady, Habib
    Kilgo, Patrick D.
    Guyton, Robert A.
    Puskas, John D.
    ANNALS OF THORACIC SURGERY, 2011, 92 (05): : 1695 - 1701
  • [28] Multivessel Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in ESRD
    Chang, Tara I.
    Shilane, David
    Kazi, Dhruv S.
    Montez-Rath, Maria E.
    Hlatky, Mark A.
    Winkelmayer, Wolfgang C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (12): : 2042 - 2049
  • [29] Prevalence and Procedural Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in Patients with Diabetes and Multivessel Coronary Artery Disease
    Mokadam, Nahush A.
    Melford, Ryland E., Jr.
    Maynard, Charles
    Goss, John R.
    Stewart, Douglas
    Reisman, Mark
    Aldea, Gabriel S.
    JOURNAL OF CARDIAC SURGERY, 2011, 26 (01) : 1 - 8
  • [30] Formula to Predict Functional Capacity in Patients with Multivessel Coronary Artery Disease After Coronary Artery Bypass Grafting Surgery
    Zuhri, Ervan
    Ambari, Ade M.
    Dwiputra, Bambang
    Radi, Basuni
    Kusmana, Dede
    Setianto, Budhi
    Santoso, Anwar
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0F) : F106 - F107